Across TCGA pan-cancer cohorts, CCR10 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated CCR10 data layer compared with 8 for mutation status.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CCR10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCR10 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CESC show a favorable association.
KIRP, HNSC, and UVM are the cancer types where CCR10 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.